Call Us + 33 1 84 88 31 00

Article R5141-94 of the French Public Health Code

The Agence nationale de sécurité sanitaire de l’alimentation, de l’environnement et du travail is responsible for implementing the national veterinary pharmacovigilance system. It leads and coordinates the actions of the various parties involved. It compiles the information collected and ensures compliance with the monitoring procedures organised by this section. It organises the dissemination of information relating to veterinary pharmacovigilance. It receives the declarations and reports sent to its Director General,…

Read More »

Article R5141-95 of the French Public Health Code

The Director General of the Agence nationale de sécurité sanitaire de l’alimentation, de l’environnement et du travail may ask veterinary pharmacovigilance centres to carry out veterinary pharmacovigilance investigations and work. It may also ask the poison control centres mentioned in article L. 6141-4 to provide it with the information and carry out the studies it considers useful for veterinary pharmacovigilance purposes. It may also ask the Director General of the…

Read More »

Article R5141-96 of the French Public Health Code

The Director General of the Agence nationale de sécurité sanitaire de l’alimentation, de l’environnement et du travail shall inform the European Medicines Agency, the other Member States of the European Union, the Director General of the Agence nationale de sécurité du médicament et des produits de santé and the company operating the veterinary medicinal product of any suspected serious adverse reaction and any suspected adverse reaction in humans which has…

Read More »

Article R5141-96-1 of the French Public Health Code

The Director General of the Agence nationale de sécurité sanitaire de l’alimentation, de l’environnement et du travail shall immediately inform the European Medicines Agency and the other Member States of the European Union of any proposal to suspend, revoke or vary ex officio a marketing authorisation based on the evaluation of pharmacovigilance data with a view to reducing the indications or availability, amending the dosage, adding a contraindication or a…

Read More »

Article R5141-101 of the French Public Health Code

Veterinary pharmacovigilance centres are responsible for : 1° Receiving reports sent, in application of article R. 5141-103, by veterinarians, pharmacists and any member of a health profession or any person who has observed an adverse reaction in an animal; 2° Gathering information of the same nature sent to them by any member of a health profession; 3° To send a detailed quarterly report to the Director General of the Agence…

Read More »

Article R5141-102 of the French Public Health Code

The creation, organisation and funding of veterinary pharmacovigilance centres, as well as the conditions under which they carry out the tasks entrusted to them by the Agence nationale de sécurité sanitaire de l’alimentation, de l’environnement et du travail, are the subject of agreements between the Director General of the Agence nationale de sécurité sanitaire de l’alimentation, de l’environnement et du travail and the national veterinary schools within which the centres…

Read More »

Article R5141-103 of the French Public Health Code

A veterinarian who has observed, or to whom has been reported, a serious or unexpected adverse reaction which may be attributed to the use of a veterinary medicinal product, whether or not he has prescribed it, or a medicinal product for human use administered to an animal under the conditions provided for in a of 3° of article L. 5143-4, shall immediately report it to the Agence nationale de sécurité…

Read More »

Article R5141-104 of the French Public Health Code

A company operating a veterinary medicinal product must: 1° Keep detailed records of all suspected adverse reactions which have occurred inside or outside the European Union; 2° To record any suspected serious adverse reaction in animals and any suspected adverse reaction in humans resulting from the use of veterinary medicinal products, as well as any suspected transmission of infectious agents by veterinary medicinal products, of which he is aware or…

Read More »

Article R5141-105 of the French Public Health Code

Without prejudice to the conditions laid down when the marketing authorisation is granted pursuant to the provisions of the fourth paragraph of Article L. 5141-5, the company operating the veterinary medicinal product shall forward to the Director General of the Agence nationale de sécurité sanitaire de l’alimentation, de l’environnement et du travail, in the form of a periodic safety update report, information relating to the adverse reactions which it has…

Read More »

Article R5141-105-1 of the French Public Health Code

The holder of an authorisation referred to in Article L. 5141-12 must report to the Director General of the Agence nationale de sécurité sanitaire de l’alimentation, de l’environnement et du travail, immediately after becoming aware of any suspected serious adverse reaction in animals and any suspected adverse reaction in humans which may be due to an auto-vaccine for veterinary use. It sends the Director General of the Agence nationale de…

Read More »

Contact a French lawyer now

Contact a French Business Lawyer

Our French business lawyers are here to help.
We offer a FREE evaluation of your case.
Call us at +33 (0) 1 84 88 31 00 or send us an email.

Useful links

You have a question in French Business Law?

Our French business lawyers are here to help.
We offer a FREE evaluation of your case.
Call +33 (0) 1 84 88 31 00 or send us an email.

All information exchanged through this website will be communicated to lawyers registered with a French Bar and will remain confidential.